Thyroid cancer trials in Spain
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peoplePhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Where
- Barcelona, Madrid, Pamplona, Valencia
- Age
- 18 years and over
- People
- 554 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00 - No phaseTaking peopleGETNE Registration of Thyroid Cancer
- Where
- Barcelona
- Age
- 18 years and over
- People
- 20
- Run by
- Grupo Espanol de Tumores Neuroendocrinos
See details and how to joinNCT03765333 - Phase 1Taking peoplePhase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
- Where
- Barcelona, Madrid
- Age
- 18 years to 100 years
- People
- 116 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00 - Phase 2Taking peopleSacituzumab govitEcan in THYroid Cancers
- Where
- Barcelona, Ferrol, Hospitalet de Llobregat (Barcelona), Madrid, Murcia, Oviedo, Santander, Zaragoza
- Age
- 18 years and over
- People
- 42
- Run by
- Grupo Espanol de Tumores Neuroendocrinos
See details and how to joinNCT06235216 - Phase 4Taking peoplePralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors
- Where
- Logroño, Madrid
- Age
- 18 years and over
- People
- 12
- Run by
- Rigel Pharmaceuticals
See details and how to joinNCT07704658 - Phase 2Taking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Barcelona, Madrid, Santiago de Compostela, Sevilla, Valencia
- Age
- 8 years and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - Phase 1/2Taking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Barcelona, Madrid
- Age
- 12 years and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - Phase 2Taking peopleA multicenter, open label, two cohort, single arm, phase II study to evaluate the efficacy and safety of the anti-TROP2 antibody-drug conjugate sacituzumab govitecan in patients with advanced differentiated and anaplastic thyroid neoplasms.
- Where
- Barcelona, Ferrol, L'hospitalet De Llobregat, Madrid, Murcia, Oviedo, Santander, Zaragoza
- Age
- 18 years and over
- People
- 42
- Run by
- Grupo Espanol De Tumores Neuroendocrinos
See details and how to join2023-504898-20-00 · EU 2023-504898-20-00 - Phase 2Taking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Valencia
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00